Belite Bio (BLTE) Invested Capital (2020 - 2025)
Belite Bio's quarterly Invested Capital came in at $770.5 million in Q4 2025, up 428.38% year-on-year from $145.8 million in Q4 2024, and up 428.38% quarter-over-quarter from $145.8 million in Q4 2024.
Belite Bio has reported Invested Capital for 6 years, with the latest figure at $770.5 million in Q4 2025.
- For the quarter ending Q4 2025, Invested Capital rose 428.38% year-over-year to $770.5 million; the trailing twelve-month figure through Dec 2025 stood at $770.5 million (up 428.38% YoY), and the FY2025 full-year result was $770.5 million, up 428.38% from the prior year.
- Invested Capital for Q4 2025 stood at $770.5 million, up from $145.8 million in the prior quarter.
- The five-year high for Invested Capital was $770.5 million in Q4 2025, with the low at -$15.0 million in Q4 2021.
- Average Invested Capital over 5 years is $206.6 million, with a median of $90.4 million recorded in 2023.
- Year-over-year, Invested Capital sank 113.47% in 2021 and jumped 428.38% in 2025.
- Tracing BLTE's Invested Capital over 5 years: stood at -$15.0 million in 2021, then surged by 376.27% to $41.5 million in 2022, then soared by 117.9% to $90.4 million in 2023, then jumped by 61.25% to $145.8 million in 2024, then jumped by 428.38% to $770.5 million in 2025.
- The last three Invested Capital figures came in at $770.5 million (Q4 2025), $145.8 million (Q4 2024), and $90.4 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Belite Bio | 4.92 Bn | 4.45 Bn | - | 770.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 770.49 Mn |
| Sep 30, 2025 | 274.08 Mn |
| Jun 30, 2025 | 149.89 Mn |
| Mar 31, 2025 | 158.07 Mn |
| Dec 31, 2024 | 145.82 Mn |
| Sep 30, 2024 | 112.20 Mn |
| Jun 30, 2024 | 114.59 Mn |
| Mar 31, 2024 | 96.47 Mn |
| Dec 31, 2023 | 90.43 Mn |
| Sep 30, 2023 | 52.79 Mn |
| Jun 30, 2023 | 55.72 Mn |
| Mar 31, 2023 | 35.17 Mn |
| Dec 31, 2022 | 41.50 Mn |
| Dec 31, 2021 | -15.02 Mn |
| Dec 31, 2020 | -7.04 Mn |